When once-a-day HIV medications became commonplace several years back, they revolutionized HIV treatment and helped make taking meds a much less intrusive part of people's daily lives.
Now just imagine what once-a-month HIV medications could do.
That pipe dream may not be so far from reality as it once seemed. This year, we learned much about a couple of "long-acting antiretroviral" candidates in the works. Most notable among these is GSK1265744 -- which, although it may need to be injected, is being engineered so that it only has to be taken once every four weeks at the most.
Early clinical trials involving these drugs have shown promising results. Now, to be sure, it's not a guarantee they'll work out, and many months of study lie ahead before we can even begin to entertain the idea that they'll become a part of regular HIV care. But it sure is an exciting concept to consider, all the more because it may be achievable.
Comment by: P. Kevin Parker
Sat., Feb. 15, 2014 at 6:53 am UTC
The article summary states that testing patients only once a year for CD4 counts will save the medical industry $41,000 per patient. That's not what the original research said, according to the full article. The researcher calculated the medical savings of only one test per year in the 550 enrolled in the study's cohort. Not per patient.
Comment by: Reader
Mon., Jan. 27, 2014 at 7:37 pm UTC
The most important point of the "Baby Cure Commotion" should have been stated as the fact that the treatment guidelines were ignored.
What that tells us is that far too little effort/resources have been directed at very early treatment over the last two decade.
And where is the mention of the latest news that HIV is not directly killing CD4+ T cells?
That news tells us that far too little effort/resources have been directed at the pathogenesis of HIV/AIDS. The argument that "researchers were simply looking in the wrong place" (and missed the main pathogenic mechanism) is an excuse that begs for better over-sight of HIV/AIDS research in general.
(Please note: Your name and comment will be public, and may even show up in Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.)
The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.